Australia
October 25, 2022
The Gene Technology Regulator is assessing an application from International Flower Developments Pty Ltd for commercial import and distribution of chrysanthemums genetically modified (GM) for altered flower colour. The GM chrysanthemum cut flowers would be sold Australia-wide but are not intended for human food.
The Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) for this application and welcomes written submissions relating to the protection of human health and safety and the environment prior to making a decision on whether to issue the licence.
The consultation RARMP and related information can be obtained via our website, or from the contacts below. Submissions should reference DIR 191 and be received by 20 December 2022.
Office of the Gene Technology Regulator
MDP 54 GPO Box 9848 CANBERRA ACT 2601
Telephone: 1800 181 030 OGTR Website
E-mail: ogtr@health.gov.au
DIR 191
Commercial import and distribution of chrysanthemum genetically modified for altered flower colour
Licence details
Licence number: DIR 191
Licence status: Application under evaluation
Category: Agricultural
Release: Commercial
Organisation: International Flower Developments Pty Ltd
Date application received: 18 February 2022
RARMP open for public consultation: 25 October 2022
RARMP closed for public consultation: 20 December 2022
Documents
Licence application - invitation to comment
An invitation for written submissions from the public on the consultation version of the Risk Assessment and Risk Management Plan. It also explains how the public can access the consultation documents and the due date for submissions.
Licence application - Q&A
FAQs on the licence application and a brief outline of the assessment and public consultation processes.
Risk assessment and risk management plan (consultation) - summary
A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
Risk assessment and risk management plan (consultation) - full version
A draft risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s).
Topics
Species
